Analysis
View More
Download our latest Newsletter
Themes
View MoreObvioHealth Q&A: connecting DCT dots with remote tech
The move towards decentralised clinical trials has been accelerated by Covid-19, and the tech that underpins remote trials is evolving…
More themes
Thematic Buyer's Guides
View More
GlobalData Reports
View More
There aren't available reports.
Insights
View MoreWhy single biomarkers are no longer enough: a new paradigm in colorectal cancer
In colorectal cancer (CRC), biomarkers have long been used to decide if patients are eligible for a particular therapy or clinical trial. The underlying logic is straightforward: match the target,…
More insights
Digital Magazine
View More
MINE Magazine
MINE Magazine is free to read on all devices including mobile and iPad. You can read the latest issue here or browse the archive for back issues. Subscribe to MINE Magazine and never miss an issue.
Comment
View MoreWhy single biomarkers are no longer enough: a new paradigm in colorectal cancer
In colorectal cancer (CRC), biomarkers have long been used to decide if patients are eligible for a particular therapy or clinical trial. The underlying logic is straightforward: match the target,…
Enhancing clinical trials with real-world data
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technology
2026: The time for AI to really deliver
The early phase advantage: the key to de-risking your clinical trials